Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,446 | 1 | 83.8% |
| Food and Beverage | $188.01 | 5 | 10.9% |
| Education | $91.99 | 1 | 5.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,674 | 4 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $33.65 | 2 | $0 (2017) |
| Hologic Sales and Service, LLC | $17.94 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.94 | 1 | Hologic Sales and Service, LLC ($17.94) |
| 2021 | $1,674 | 4 | Applied Medical Resources Corporation ($1,674) |
| 2017 | $33.65 | 2 | Merck Sharp & Dohme Corporation ($33.65) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2024 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Surgical | ||||||
| 07/16/2021 | Applied Medical Resources Corporation | GelPOINT V-Path (Device), GelPOINT V-Path | Travel and Lodging | Cash or cash equivalent | $1,445.66 | General |
| Category: SPECIALTY ACCESS | ||||||
| 07/16/2021 | Applied Medical Resources Corporation | GelPOINT V-Path (Device), GelPOINT V-Path | Education | Cash or cash equivalent | $91.99 | General |
| Category: SPECIALTY ACCESS | ||||||
| 07/16/2021 | Applied Medical Resources Corporation | GelPOINT V-Path (Device), GelPOINT V-Path | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: SPECIALTY ACCESS | ||||||
| 06/13/2021 | Applied Medical Resources Corporation | — | Food and Beverage | In-kind items and services | $114.41 | General |
| 06/28/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: WOMENS HEALTH | ||||||
| 04/25/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 358 | 373 | $79,246 | $20,927 |
| 2022 | 5 | 279 | 294 | $62,970 | $17,440 |
| 2021 | 6 | 316 | 325 | $69,767 | $18,731 |
| 2020 | 8 | 295 | 303 | $79,291 | $18,865 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 220 | 220 | $46,200 | $10,289 | 22.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 92 | $21,160 | $6,766 | 32.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 34 | 34 | $5,746 | $1,728 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 11 | $3,740 | $1,299 | 34.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $2,400 | $844.96 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 95 | $21,850 | $7,369 | 33.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 141 | 141 | $29,610 | $6,724 | 22.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 35 | 35 | $5,915 | $1,805 | 30.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,795 | $1,042 | 27.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,800 | $499.88 | 27.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 180 | 180 | $37,800 | $8,647 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 51 | $11,730 | $3,756 | 32.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 48 | 48 | $8,112 | $2,544 | 31.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $7,590 | $2,378 | 31.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $2,585 | $705.80 | 27.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 13 | $1,950 | $700.31 | 35.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 143 | 143 | $30,030 | $6,980 | 23.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 49 | $11,270 | $3,280 | 29.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 28 | 29 | $10,005 | $2,581 | 25.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 29 | 29 | $4,901 | $1,495 | 30.5% |
| 58100 | Biopsy of uterine lining | Office | 2020 | 15 | 15 | $9,600 | $1,443 | 15.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 13 | $4,420 | $1,103 | 25.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $5,775 | $1,040 | 18.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 14 | 14 | $3,290 | $943.22 | 28.7% |
About Dr. Rochelle Joly, MD
Dr. Rochelle Joly, MD is a Gynecology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1780977108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rochelle Joly, MD has received a total of $1,726 in payments from pharmaceutical and medical device companies, with $17.94 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Travel and Lodging" ($1,446).
As a Medicare-enrolled provider, Joly has provided services to 1,248 Medicare beneficiaries, totaling 1,295 services with total Medicare billing of $75,962. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Brooklyn, NY
- Active Since 05/18/2011
- Last Updated 09/24/2015
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1780977108
Products in Payments
- GelPOINT V-Path (Device) $1,560
- NUVARING (Drug) $33.65
- ACESSA PROVU SYSTEM (Device) $17.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Brooklyn
Ghadir Salame, Md, MD
Gynecology — Payments: $210,003
Eung-Mi Lee, M.d, M.D
Gynecology — Payments: $8,015
Dr. Mark Vaynkhadler, M.d, M.D
Gynecology — Payments: $4,524
Irina Cherepashinskaya-Vaizman, M.d, M.D
Gynecology — Payments: $1,605
Aggie Smith, Np, NP
Gynecology — Payments: $1,544
Dr. Dmitriy Bronfman, M.d, M.D
Gynecology — Payments: $629.49